Destabilization of natriuretic peptide C-receptor mRNA by phorbol myristate acetate

Journal of the American Society of Nephrology

Volumn 9, Issue 1, 1998, Pages 26-32

  Paul, Richard V ^a   Wackym, Pamela S ^a   Budisavljevic, Milos N ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOHEXIMIDE; DACTINOMYCIN; MESSENGER RNA; NATRIURETIC PEPTIDE TYPE C; PHORBOL 13 ACETATE 12 MYRISTATE; PLATELET DERIVED GROWTH FACTOR; PROTEIN KINASE C; RECEPTOR;

ADOLESCENT; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENETIC TRANSCRIPTION; MALE; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; RNA TRANSCRIPTION;

EID: 0031976023     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Koller KJ, Lowe DG, Bennett GL, Minamino N, Kangawa K, Matsuo H, Goeddel DV: Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP). Science 252: 120-123, 1991
2. Garbers DL: Guanylyl cyclase receptors and their ligands. Adv Second Messenger Phosphoprotein Res 28: 91-95, 1993
3. Brenner B, Ballermann B, Gunning M, Zeidel M: Diverse biological actions of atrial natriuretic peptide. Physiol Rev 70: 665-699, 1990
4. Fuller F, Porter J, Arfsten A, Miller J, Schilling J, Scarborough R, Lewicki J, Schenk D: Atrial natriuretic peptide clearance receptor. J Biol Chem 263: 9395-9401, 1988
5. Hu RM, Levin ER, Pedram A, Frank HJ: Atrial natriuretic peptide inhibits the production and secretion of endothelin from cultured endothelial cells: Mediation through the C receptor. J Biol Chem 267: 17384-17389, 1992
6. Trachte GJ, Kanwal S, Elmquist BJ, Ziegler RJ: C-type natriuretic peptide neuromodulates via "clearance" receptors. Am J Physiol 268: C978-C984, 1995
7. McLay J, Chatterjee P, Jardine A, Hawksworth G: Atrial natriuretic factor inhibits the induction of nitric oxide synthase via a cGMP independent mechanism: Evidence for a novel immuno-modulatory function for the ANF clearance receptor [Abstract]. J Am Soc Nephrol 5: 664, 1994
8. McLay JS, Chatterjee PK, Jardine AG, Hawksworth GM: Atrial natriuretic factor modulates nitric oxide production: An ANF-C receptor-mediated effect. J Hypertens 13: 625-630, 1995
9. Cahill PA, Hassid A: Clearance receptor-binding atrial natriuretic peptides inhibit mitogenesis and proliferation of rat aortic smooth muscle cells. Biochem Biophys Res Commun 179: 1606-1613, 1991
10. Levin ER, Frank HJ: Natriuretic peptides inhibit rat astroglial proliferation: Mediation by C receptor. Am J Physiol 261: R453-R457, 1991
11. Rashed HM, Sun H, Patel TB: Atrial natriuretic peptide inhibits growth of hepatoblastoma (HEP G2) cells by means of activation of clearance receptors. Hepatology 17: 677-684, 1993
12. Kishimoto I, Yoshimasa T, Suga S, Ogawa Y, Komatsu Y, Nakagawa O, Itoh H, Nakao K: Natriuretic peptide clearance receptor is transcriptionally down-regulated by beta 2-adrenergic stimulation in vascular smooth muscle cells. J Biol Chem 269: 28300-28308, 1994
13. Paul R, Wackym P, Budisavljevic M, Everett E, Norris J: Regulation of atrial peptide receptors in mesangial cells by growth factors. J Biol Chem 268: 18205-18212, 1993
14. Lovett D, Sterzel R, Kashgarian M, Ryan J: Neutral proteinase activity produced in vitro by cells of the glomerular mesangium. Kidney Int 23: 342-349, 1983
15. Saxenhofer H, Fitzgibbon WF, Paul RV: Urodilatin: Binding properties and stimulation of cGMP generation in rat kidney cells. Am J Physiol 264: F267-F273, 1993
16. Engel AM, Schoenfeld JR, Lowe DG: A single residue determines the distinct pharmacology of rat and human natriuretic peptide receptor-C. J Biol Chem 269: 17005-17008, 1994
17. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987
18. Lowry O, Roseborough N, Fair A, Randall R: Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951
19. Ardaillou N, Blaise V, Placier S, Amestoy F, Ardaillou R: Dexamethasone upregulates ANP C-receptor protein in human mesangial cells without affecting mRNA. Am J Physiol 270: F440-F446, 1996
20. Iida H, Seifert R, Alpers CE, Gronwald RG, Phillips PE, Pritzl P, Gordon K, Gown AM, Ross R, Bowen-Pope DF, Johnson RJ: Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat. Proc Natl Acad Sci USA 88: 6560-6564, 1991
21. Prins B, Weber M, Hu R, Pedram A, Daniels M, Levin E: Atrial natriuretic peptide inhibits mitogen-activated protein kinase through the clearance receptor. J Biol Chem 271: 14156-14162, 1996
22. Zhu Y, Schwartz R, Crow M: Gene expression in terminally differentiated myotubes through transcriptional repression and message destabilization. J Cell Biol 115: 745-754, 1991
23. Saceda M, Knabbe C, Dickson R, Lippman M, Bronzen D, Lindsey R, Gottardis M, Martin M: Post-transcriptional destabilization of estrogen receptor mRNA in MCF-7 cells by 12-O-tetradecanoyl-phorbol-13-acetate. J Biol Chem 266: 17809-17814, 1991
24. Zinck R, Cahill MA, Kracht M, Sachsenmaier C, Hipskind RA, Nordheim A: Protein synthesis inhibitors reveal differential regulation of mitogen-activated protein kinase and stress-activated protein kinase pathways that converge on Elk-1. Mol Cell Biol 15: 4930-4938, 1995
25. Peppel K, Vinci J, Baglioni C: The AU-rich sequences in the 3′ untranslated region mediate the increased turnover of interferon mRNA induced by glucocorticoids. J Exp Med 173: 349-355, 1991
26. Maack T, Suzuki M, Almeida F, Nussenzveig D, Scarborough R, McEnroe G, Lewicki J: Physiological role of silent receptors of atrial natriuretic factor. Science 238: 675-678, 1987